MetLife, Inc. $MET Position Decreased by Cyndeo Wealth Partners LLC

Cyndeo Wealth Partners LLC lowered its position in MetLife, Inc. (NYSE:MET) by 21.2% during the third quarter, Holdings Channel reports. The institutional investor owned 109,271 shares of the financial services provider’s stock after selling 29,450 shares during the quarter. Cyndeo Wealth Partners LLC’s holdings in MetLife were worth $10,289,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of MET. Pension & Wealth Management Advisors Inc. boosted its stake in MetLife by 62.0% in the third quarter. Pension & Wealth Management Advisors Inc. now owns 810 shares of the financial services provider’s stock valued at $76,000 after acquiring an additional 310 shares in the last quarter. Cantor Fitzgerald Investment Advisors L.P. increased its position in shares of MetLife by 2.1% during the third quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 175,989 shares of the financial services provider’s stock worth $16,571,000 after purchasing an additional 3,557 shares in the last quarter. V Square Quantitative Management LLC increased its position in shares of MetLife by 0.5% during the third quarter. V Square Quantitative Management LLC now owns 40,436 shares of the financial services provider’s stock worth $3,807,000 after purchasing an additional 200 shares in the last quarter. AdvisorNet Financial Inc lifted its holdings in shares of MetLife by 40.5% during the 3rd quarter. AdvisorNet Financial Inc now owns 2,088 shares of the financial services provider’s stock valued at $208,000 after purchasing an additional 602 shares during the last quarter. Finally, Nvwm LLC lifted its holdings in shares of MetLife by 655.3% during the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 249 shares during the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
• Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
• Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
• Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on MET shares. UBS Group raised their price objective on MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, October 6th. Jefferies Financial Group upped their target price on MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Bank of America decreased their price target on MetLife from $106.00 to $103.00 and set a “buy” rating for the company in a research note on Wednesday, July 15th. Evercore reissued a “mixed” rating on shares of MetLife in a report on Monday, August 24th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of MetLife in a research note on Friday, September 11th. Thirteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $105.19.

MetLife Trading Up 0.5%

Shares of MetLife stock opened at $100.73 on Friday. The firm’s 50 day simple moving average is $96.87 and its two-hundred day simple moving average is $88.73. The firm has a market capitalization of $64.82 billion, a price-to-earnings ratio of 10.26, a PEG ratio of 0.95 and a beta of 0.78. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $102.43. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, topping the consensus estimate of $2.30 by $0.13. The business had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.02 earnings per share. Analysts predict that MetLife, Inc. will post 9.93 EPS for the current year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio (DPR) is 45.40%.

MetLife announced that its Board of Directors has approved a share buyback plan on Wednesday, August 5th that permits the company to buy back $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to buy up to 4.8% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

About MetLife

MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.

The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.

Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.